Wireless usage spikes in 2025, networks strain
This Is Important Because: The data highlights a growing dependency on wireless networks, especially among younger users, pushing carriers to their limits. As streaming becomes ubiquitous, networks face increased strain, leading to more dropped calls and slower load times. This study, based on 27,528 customer responses from July to December 2024, shows carriers must adapt to meet rising demands. We've previously noted 5G's role in reducing issues, but the latest data suggests even 5G struggles under heavy loads.
Recommended Videos
Why I Should Care? If you're streaming or gaming on the go, network hiccups could disrupt your experience. The increase in problems—two more per 100 uses—means you might face more buffering or dropped connections. Choosing a carrier like Verizon or T-Mobile, depending on your region, could improve reliability.
OK, What's Next? Carriers need to bolster infrastructure, especially mid-band 5G, to handle data-heavy tasks. Consumers should monitor carrier performance in their region and consider switching if issues persist. For more, check J.D. Power's full report or Digital Trends' coverage on 5G advancements.
FYI: A 2024 study from the Journal of Behavioral Addictions links heavy phone use—over six hours daily—to increased anxiety and depression, especially in Gen Z and Gen Y. Social media and gaming, key drivers of the 40-minute usage spike, correlate with reduced attention spans and sleep issues. The study, based on 5,000 young adults, suggests mindful usage and screen-time limits to mitigate risks as wireless dependency grows.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
Google failed to warn 10 million of Turkey earthquake
Google has admitted its earthquake early warning system failed to accurately alert people during Turkey's deadly quake of 2023. Ten million people within 98 miles of the epicentre could have been sent Google's highest level alert - giving up to 35 seconds of warning to find safety. Instead, only 469 "Take Action" warnings were sent out for the first 7.8 magnitude quake. Google told the BBC half a million people were sent a lower level warning, which is designed for "light shaking", and does not alert users in the same prominent way. The tech giant previously told the BBC the system had "performed well". The system works on Android devices, which make up more than 70% of the phones in Turkey. More than 55,000 people died when two major earthquakes hit south-east Turkey on 6 February 2023, more than 100,000 were injured. Many were asleep in buildings that collapsed around them when the tremors hit. Google's early warning system was in place and live on the day of the quakes – however it underestimated how strong the earthquakes were. "We continue to improve the system based on what we learn in each earthquake", a Google spokesperson said. How it works Google's system, named Android Earthquake Alerts (AEA), is able to detect shaking from a vast number of mobile phones that use the Android operating system. Because earthquakes move relatively slowly through the earth, a warning can then be sent out. Google's most serious warning is called "Take Action", which sets off a loud alarm on a user's phone - overriding a Do Not Disturb setting - and covering their screen. This is the warning that is supposed to be sent to people when stronger shaking is detected that could threaten human life. AEA also has a less serious "Be Aware" warning, designed to inform users of potential lighter shaking - a warning that does not override a device on Do Not Disturb. The Take Action alert was especially important in Turkey due to the catastrophic shaking and because the first earthquake struck at 04:17, when many users would have been asleep. Only the more serious alert would have woken them. In the months after the earthquake the BBC wanted to speak to users who had been given this warning - initially with aims to showcase the effectiveness of the technology. But despite speaking to people in towns and cities across the zone impacted by the earthquake, over a period of months, we couldn't find anyone who had received a more serious Take Action notification before the quake struck. We published our findings later that year. 'Limitations' Google researchers have written in the Science journal details of what went wrong, citing "limitations to the detection algorithms". For the first earthquake, the system estimated the shaking at between 4.5 and 4.9 on the moment magnitude scale (MMS) when it was actually a 7.8. A second large earthquake later that day was also underestimated, with the system this time sending Take Action alerts to 8,158 phones and Be Aware alerts to just under four million users. After the earthquake Google's researchers changed the algorithm, and simulated the first earthquake again. This time, the system generated 10 million Take Action alerts to those at most risk – and a further 67 million Be Aware alerts to those living further away from the epicentre "Every earthquake early warning system grapples with the same challenge - tuning algorithms for large magnitude events," Google told the BBC. But Elizabeth Reddy, assistant professor at Colorado School of Mines, says it is concerning it took more than two years to get this information. "I'm really frustrated that it took so long," she said "We're not talking about a little event - people died - and we didn't see a performance of this warning in the way we would like." Google says the system is supposed to be supplementary and is not a replacement for national systems. However some scientists worry countries are placing too much faith in tech that has not been fully tested. "I think being very transparent about how well it works is absolutely critical," Harold Tobin, director of the Pacific Northwest Seismic Network, told the BBC. "Would some places make the calculation that Google's doing it, so we don't have to?" Google researchers say post-event analysis has better improved the system - and AEA has pushed out alerts in 98 countries. The BBC has asked Google how AEA performed during the 2025 earthquake in Myanmar, but has yet to receive a response. How a grieving mother exposed the truth of Turkey's deadly earthquake Beverley man remembers family lost in Turkey quake Sign up for our Tech Decoded newsletter to follow the world's top tech stories and trends. Outside the UK? Sign up here.
Android Authority
2 hours ago
- Android Authority
Samsung may be killing bootloader unlocking on all phones with One UI 8
Joe Maring / Android Authority TL;DR Samsung appears to be disabling bootloader unlocking in One UI 8 on more devices than before. Previously, only US models lacked the OEM Unlock toggle, but the restriction now seems to be spreading to global models as well. A contributor on XDA Developers discovered that Samsung is likely stripping out the necessary code to unlock bootloaders entirely. Samsung might be quietly locking down its phones even more tightly with the One UI 8 update. A new report from an XDA Developers contributor reveals that Samsung appears to be removing the ability to unlock the bootloader on more devices, including international versions that previously supported it. Samsung phones in the US already lack the 'OEM Unlocking' toggle in Developer Options, effectively preventing users from unlocking the bootloader and installing custom ROMs. But now, it looks like that restriction could apply globally. What's changed? The contributor, salvo_giangri, discovered that Samsung has added a line to the device's bootloader configuration: This line tells the Android system whether the device is allowed to unlock the bootloader. If it's set to 1, the Settings app won't even show the OEM Unlock option, which is the first step in unlocking a phone. In the latest One UI 8 firmware, this line is present even on non-US devices, indicating that the restriction is no longer region-specific. We checked and can confirm that our non-US Galaxy Z Fold 7 does not have the 'OEM Unlocking' toggle in Developer Options. Some folks think this could be a mistake on Samsung's part. However, those running the One UI 8 beta build also report that the option is missing from their devices. Unlocking the bootloader is essential for enthusiasts and developers who want to install custom ROMs or kernels, gain full root access to their devices, or further customize their phones. If you're someone who loves customizing your phone or values the freedom to tinker with Android, then this is a significant step back from Samsung. Anyone planning to update to One UI 8 or buy a new Samsung device running Android 16 should know that this restriction may apply to their devices. That said, we'll reach out to Samsung for an official confirmation on the matter. For now, the bootloader on your current Samsung devices that are not running One UI 8 should still be unlockable, but with new updates and devices, that may no longer be the case.
Yahoo
5 hours ago
- Yahoo
Elpis Biopharmaceuticals Signs Memorandum of Understanding with National Cancer Centre Singapore to Conduct Translational Cell Therapy Research in Singapore
Collaboration focuses on advancing clinically validated armored CAR technologies into first-in-human trials in Singapore and accelerate translational research from bench-to-bedside SINGAPORE and LEXINGTON, Mass., July 28, 2025 /PRNewswire/ -- Elpis Biopharmaceuticals, a clinical-stage cell therapy company developing bispecific armored CAR-T therapies for solid tumors, today announced the signing of a Memorandum of Understanding (MOU) with the National Cancer Centre Singapore (NCCS). The partnership aims to support collaborative cell therapy research and clinical trials for the treatment of a variety of cancers, including colorectal, pancreatic and ovarian cancers. CAR-T cell therapy is a form of immunotherapy that is currently only approved for use to treat blood cancers, such as certain types of lymphomas and multiple myeloma. As part of the agreement, Elpis will contribute clinically validated technologies for cancer treatment, including multi-mechanism armor, bispecific targeting antibodies, cytokine cocktails, and a rapid mRNA display discovery engine, to drive the development of next-generation cell therapies. These technologies are already being investigated in Elpis' global clinical trials of EPC-002 and EPC-003, with the goal of expanding their translational relevance across multiple tumor types. Plans are also underway for Elpis to establish a laboratory space at NCCS and co-share its equipment to enable more integrated and efficient collaboration. "This partnership reflects our commitment to rapidly advancing innovative immunotherapies from discovery to clinical development through to regulatory review and, hopefully saving patients' lives," said Yan Chen, MD, PhD, Founder and CEO of Elpis Biopharmaceuticals. "By combining Elpis's proprietary technology with NCCS's clinical expertise, we look forward to accelerating the delivery of these potential groundbreaking new cancer therapies to patients in Singapore and beyond." NCCS will contribute its expertise in clinical research and access to clinical trial infrastructure to support the evaluation of novel cell therapy candidates. "The potential of using cell therapies for solid tumors is still being explored, and this collaboration will enable us to evaluate promising new technologies in a clinical context to address current unmet needs and improve patient outcomes," said Professor Lim Soon Thye, CEO of NCCS. "This is a key collaboration with NCCS' precision immunotherapy program. With our respective strengths and the shared goal of transforming clinical care through translational science, we look forward to offering clinical trials and developing novel cell therapies to better meet the needs of patients in Singapore and the region," added Professor Daniel Tan, Head, Division of Clinical Trials and Epidemiological Sciences and Senior Consultant, NCCS. The collaboration will support the development of bispecific armored CAR-T cell therapies for solid tumors, while Elpis's global leading mRNA display technology will support NCCS in the rapid discovery of human antibodies to novel targets and enable novel modalities to cell therapy and beyond. "The MOU represents an expansion of Elpis's living drug strategy and a key step toward enabling broader clinical translation of our cutting-edge cell therapy technologies," said Chee-Yong Lim, Co-Founder, Co-CEO & Chief Strategy Officer, Elpis Biopharmaceuticals. "Together, we are working to make living drugs a reality for patients with cancers that currently lack effective treatment options." About Elpis Biopharmaceuticals Elpis Biopharmaceuticals is a clinical-stage biopharma company pioneering next-generation cell therapies for the treatment of solid tumors. The company is advancing a pipeline of first- and best-in-class bispecific armored CAR-T therapies designed to overcome the challenges of tumor heterogeneity and the immunosuppressive tumor microenvironment. Its proprietary platforms—including a multi-mechanism armor technology, bispecific targeting antibodies, a cytokine cocktail-based cell manufacturing process, and a rapid mRNA display discovery engine—are integrated to deliver safer, more durable, and more effective therapeutic responses. Elpis's lead programs include EPC-003 for glioblastoma and EPC-002 for a broad range of solid tumors. Elpis Biopharmaceuticals is headquartered in Singapore and Boston, MA. For more information, visit Contact Tiberend Strategic Advisors, Inc. Jonathan Nugent (investors) +1-205-566-3026 jnugent@ Eric Reiss (media) ereiss@ View original content: SOURCE Elpis Biopharmaceuticals Sign in to access your portfolio
